naftopidil has been researched along with Mesothelioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotoh, A; Kanno, T; Masachika, E; Nakano, T; Nishizaki, T | 1 |
| Gotoh, A; Kanno, T; Mikami, K; Nagaya, H; Nakano, T; Nishizaki, T; Tsuchiya, A | 1 |
2 other study(ies) available for naftopidil and Mesothelioma
| Article | Year |
|---|---|
Naftopidil induces apoptosis in malignant mesothelioma cell lines independently of α1-adrenoceptor blocking.
Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Humans; Mesothelioma; Naphthalenes; Piperazines | 2013 |
Naftopidil is useful for the treatment of malignant pleural mesothelioma.
Topics: Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Fas Ligand Protein; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Mice, Nude; Naphthalenes; Piperazines; RNA, Messenger; Tumor Burden; Tumor Necrosis Factor-alpha | 2014 |